Celiac disease: not as rare as previously thought
Celiac disease-once believed to be rare-actually affects up to 1% of the US population. So underdiagnosed is the problem that the National Institutes of Health convened a consensus panel, which recently announced recommendations for appropriate diagnosis and management of the disease.
Celiac disease-once believed to be rare-actually affects up to 1% of the US population. So underdiagnosed is the problem that the National Institutes of Health convened a consensus panel, which recently announced recommendations for appropriate diagnosis and management of the disease.
Diagnosis of celiac disease may take up to 10 years because symptoms-diarrhea, abdominal cramping, pain, and distention-are relatively common complaints. In addition, other effects like persistent elevation of transaminases, short stature, delayed puberty, iron-deficiency anemia, recurrent fetal loss, and infertility can lead physicians down many incorrect diagnostic paths.
Once the disease is suspected, the first step is serologic testing with either antihuman tissue transglutaminase IgA or endomysial antibody immunofluorescence IgA. Both tests have equivalent diagnostic accuracy with high sensitivity and specificity, according to the NIH panel. If a patient tests positive, the next step is to obtain biopsy specimens of the proximal small bowel.
Mitka M. Higher profile needed for celiac disease: underdiagnosis fosters treatment delays, says panel. JAMA. 2004;292:913-914.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More
